11.10.26 -- How To Stand Up A Hospital-Based CAR-T Manufacturing Network

Discover how industry experts are bringing customizable automation to cell therapy manufacturing, helping reduce production costs and expand patient access across the sector.

Master the nuances of material transfer through expert-led training. Learn to assess packaging integrity, ensure complete disinfection coverage, and manage time-sensitive items with precision.

Improve accuracy and reduce stress with skillful pipetting tips. Discover how technique and tool selection can boost precision and efficiency, ensuring consistent results across every lab workflow.

Explore filtration strategies designed to maintain sample integrity by reducing particulates, and learn why choosing the correct pore size supports reliable biological workflows.

Multi-product ATMP facilities need integrated teams, flexible design, and strategic HVAC to ensure scalability, contamination control, cost efficiency, and reliable long-term performance.

Review a scalable, robust upstream process developed for viral vector production using suspension cells, and examine strategies to expand culture volume effectively.

Gene expression profiling reveals whether engineered T cells display intended molecular changes while helping identify unwanted effects. See how a standardized workflow can improve consistency.

Discover scalable strategies for high-yield adherent cell culture. Learn how gas-permeable technology optimizes MSC expansion, viral vector production, and extracellular vesicle secretion.

Particulate-related recalls account for 37% of US FDA injectable drug actions, and evolving FDA and EU GMP requirements are raising the compliance bar for manufacturers.

From harsh chemicals to gentle enzymes, explore the groundbreaking shift in nucleotide synthesis, making drug manufacturing cleaner, greener, and more efficient.

Faster timelines, cleaner manufacturing, and regulatory momentum are driving interest in synthetic DNA. See how innovators are reducing bottlenecks and accelerating development.

Emerging pharma manufacturers are compressing recipe digitalization from months to weeks, reducing human error, and accelerating time-to-market using automated template conversion.

Scaling cell and gene therapies requires automation that protects critical biology while improving consistency. Uncover why purpose-built technologies and industry collaboration will be essential.

Investigate how a refined two-step TIL selection workflow improves manufacturing from cold tumors by enriching tumor-reactive cells earlier, reducing exhausted phenotypes, and supporting stronger expansion.

Personalized cancer vaccines face a DNA production bottleneck. Synthetic approaches speed timelines, boost consistency, and simplify workflows to deliver individualized therapies faster.

In AAV manufacturing, long-term success depends not just on titers, but on maximizing the percentage of full capsids to ensure efficacy, safety, and scalability.